A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)

Clinical trial NCT00691899 · WITHDRAWN

Trial details

NCT number: NCT00691899
Sponsor: Merck Sharp & Dohme LLC
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2008-09-01
Primary completion: 2008-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.